Common menu bar links
Careers
Enquiries: NRC-BRI
Phone: 514-496-6100
Email: bri-info@cnrc-nrc.gc.ca
Montreal, NRC-BRI Research Facilities
6100 Royalmount Avenue
Montréal,
Quebec,
H4P 2R2
Canada
Driving Directions to the Montreal, NRC-BRI Research Facilities
NRC Biotechnology Research Institute Licensing Opportunities
- Anaerobic and aerobic integrated system for biotreatment of toxic wastes (L-10344)
- Cumate-inducible expression system in eukaryotic cells (L-11648 & 11225)
- Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants (L-10890)
- Efficient method for the bioremediation of nitrate-contaminated groundwater (L-11136)
- Electrolytically-enhanced anaerobic digestion (eAD) for high yield biogas production (L-12143)
- Enhanced system for baculovirus-mediated transient transgene expression L-11770
- Fast and high yield recombinant proteins production by large-scale transfection of suspension-growing mammalian cells (L-11266)
- Generating re-targeted adenoviral vectors with altered tropism (L-11498)
- Green process for the production of vinylguaiacol, a value-added product (L-11808)
- HEK293 cell line for suspension culture and serum-free production of recombinant proteins and viral vectors (L-10894)
- HEK293 mammalian cell platform for high yield production of recombinant proteins, vaccines, and viral vectors (PL-11565)
- High sensitivity, early detection tool for toxic cyanobacterial blooms (L-12151)
- Immobilization of microorganisms in chitosan for environmental applications (L-10707)
- Method for degradation of cyclic nitramines in contaminated soil, water or stockpiles (L-11425)
- Method for high-yield enzymatic synthesis of non-ionic biosurfactants (L-10269)
- More efficient and productive method for large-scale transfection of CHO cells (L-11992)
- Multi-wavelength fluorometric system for on-line monitoring of bioprocesses (L-11634)
- Muscle-mediated gene therapy (L-11887)
- New enantioselective and thermostable esterase for racemic resolution (L-11654)
- New thermostable and catalytically-enhanced pectate lyase (L-11927)
- Novel algorithm for finding robust cancer gene markers (L-12020)
- Novel Baeyer-Villiger monooxygenases as useful biocatalysts (L-11313 & 11167)
- Novel carrier proteins derived from Staphylococcus nuclease for high yield peptide production (L-11391)
- Novel gene expression system for Escherichia coli (L-11947)
- Novel rapid and sensitive on/off switch regulated by coumarin for gene expression in mammalian cells (L-11444)
- Novel yeast-based system for the detection of protein-protein interactions in the cytoplasm or on the plasma membrane (L-11681)
- Nucleic acid arrays for microorganisms detection and characterization (L-11434)
- Optimized large-scale transient gene expression with a serum-free suspension-growing HEK293 cell line (L-11565)
- Physical method for the quantification of viruses and viral particles (L-11622)
- Potent anticoagulants based on peptide inhibitors of thrombin (L-11388)
- Potent VEGF antagonists as potential therapeutic agents (L-11885)
- Powerful Methylobacterium-based technology platform for the production of recombinant proteins and other bioproducts (PL-11725)
- Protein expression technologies (PL-11404)
- Retractable bivalent polypeptide inhibitors (L-11615)
- Simple and efficient method for the large-scale production of E1 deficient adenovirus (L-10624)
- Simple, scalable and high yield method for high level production of human recombinant interferon (L-11993)
- TGF-β biologic targeted therapy for oncology, cardiovascular disease and nephrology indications (L-11817)
- Versatile and sterilizable probe for the extraction and quantification of volatile compounds in liquids (L-11320)
- Versatile water electrolysis-based approach for integrated bioremediation of liquids contaminated with chlorinated and recalcitrant compounds (L-11390)
